PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Sino Biopharmaceutical Ltd (1177.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINKYG8167W1380
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$57.34B
EPSHK$0.01
PE Ratio27.73
PEG Ratio0.49
Revenue (TTM)HK$28.86B
Gross Profit (TTM)HK$21.53B
EBITDA (TTM)HK$6.95B
Year RangeHK$2.57 - HK$4.62
Target PriceHK$4.65

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 1177.HK

Sino Biopharmaceutical Ltd

Popular comparisons: 1177.HK vs. 6078.HK

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Sino Biopharmaceutical Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


180.00%200.00%220.00%240.00%260.00%280.00%300.00%OctoberNovemberDecember2024FebruaryMarch
214.82%
266.74%
1177.HK (Sino Biopharmaceutical Ltd)
Benchmark (^GSPC)

S&P 500

Returns By Period

Sino Biopharmaceutical Ltd had a return of -13.26% year-to-date (YTD) and -28.68% in the last 12 months. Over the past 10 years, Sino Biopharmaceutical Ltd had an annualized return of -7.06%, while the S&P 500 had an annualized return of 10.96%, indicating that Sino Biopharmaceutical Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-13.26%10.04%
1 month-4.75%3.53%
6 months4.92%22.79%
1 year-28.68%32.16%
5 years (annualized)-15.17%13.15%
10 years (annualized)-7.06%10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-19.02%11.39%
2023-15.34%-5.03%8.22%26.32%-9.64%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Sino Biopharmaceutical Ltd (1177.HK) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
1177.HK
Sino Biopharmaceutical Ltd
-0.73
^GSPC
S&P 500
2.76

Sharpe Ratio

The current Sino Biopharmaceutical Ltd Sharpe ratio is -0.73. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.73
2.74
1177.HK (Sino Biopharmaceutical Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

Sino Biopharmaceutical Ltd granted a 2.66% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.08 per share.


PeriodTTM20232022202120202019201820172016201520142013
DividendHK$0.08HK$0.08HK$0.10HK$0.04HK$0.05HK$0.04HK$0.04HK$0.03HK$0.03HK$0.02HK$0.02HK$0.01

Dividend yield

2.66%2.31%2.19%0.75%0.71%0.37%0.77%0.22%0.49%0.25%0.27%0.24%

Monthly Dividends

The table displays the monthly dividend distributions for Sino Biopharmaceutical Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.06HK$0.00HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.04HK$0.00HK$0.00HK$0.06HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.02
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01
2017HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.01HK$0.00HK$0.01HK$0.00HK$0.01HK$0.00
2016HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.01
2015HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2014HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2013HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%2.7%
Sino Biopharmaceutical Ltd has a dividend yield of 2.66%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%8.3%
Sino Biopharmaceutical Ltd has a payout ratio of 8.33%, which is below the market average. This means Sino Biopharmaceutical Ltd returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-84.20%
0
1177.HK (Sino Biopharmaceutical Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Sino Biopharmaceutical Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sino Biopharmaceutical Ltd was 86.04%, occurring on Oct 4, 2023. The portfolio has not yet recovered.

The current Sino Biopharmaceutical Ltd drawdown is 84.20%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-86.04%May 29, 20181318Oct 4, 2023
-81.11%Apr 27, 20041064Oct 27, 2008384May 14, 20101448
-54.98%Nov 9, 2015155Jun 24, 2016341Nov 10, 2017496
-52.11%May 17, 2010475Apr 17, 2012165Dec 11, 2012640
-38.05%Oct 3, 20004Oct 9, 200093Feb 28, 200197

Volatility

Volatility Chart

The current Sino Biopharmaceutical Ltd volatility is 14.16%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%OctoberNovemberDecember2024FebruaryMarch
14.16%
2.82%
1177.HK (Sino Biopharmaceutical Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Sino Biopharmaceutical Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items